Pembrolizumab Combination With Lenvatinib in Pts With Recurrent,Persistent,Metastatic or Locally Advanced Vulvar Cancer Not Amenable to Curative Surgery or Radiotherapy

Clinical trial NCT05903833 · RECRUITING

Trial details

NCT number: NCT05903833
Sponsor: AGO Research GmbH
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Vulvar Cancer Persistent Vulvar Cancer Metastatic Vulva Cancer Locally Advanced Vulvar Cancer

Start date: 2025-06-24
Primary completion: 2027-10-30
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.